Non-invasive Diagnosis of Pulmonary Embolism by Use of Biomarkers in Exhaled Breath
A legfontosabb adatok
- Ki végzi
- Aalborg University Hospital
- Hol
- Dánia1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Befejeződött
- Résztvevők
- 88 fő vett részt
- Kezdés
- 2024. jan. 11.
- Befejezés
- 2024. dec. 31.
- A vizsgálat típusa
- Megfigyeléses, 3 csoport
- A vizsgált kezelések
- New method for diagnosis of pulmonary embolism (PE) in order to validate/consolidate 151 putative identified biomarkers for PE in the exhaled breath.
- A regiszteradat frissítve
- 2025. január 13.
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Részt vehetnek
A regiszter feltételei, szó szerint
Mind a 17 feltétel megnézéseKevesebb
Ki vehet részt
- Same gender and age (within a 10-year range) as an included PE patient
- Are conscious and able to understand the given study information
- Possess legal capacity
- Age above 18 years
- Informed, signed consent is obtained
Ki nem vehet részt
- Active malignant disease (i.e., ongoing anti-cancer therapy or palliation)
- Current smokers
Egyéb feltételek
- PE patients:
- Admitted to the Emergency Care Center with suspected PE
- Are conscious and able to understand the given study information
- Possess legal capacity
- Age above 18 years
- Informed, signed consent is obtained
- Clinically stable, which is defined as patients with stable blood pressure and not in need for other treatments
- No need for organ support, which comprises need for vasopressors or inotropes, mechanical ventilation, extra corporal circulation, or renal replacement therapy
- In subjects, where the PE diagnosis is rejected after diagnostic work-up will be included in as clinical controls; Healthy controls:; The healthy age- and gender matched controls will be recruited as a:
- Random sample from the background population who wants to participate voluntarily on a first come, first served basis. They will be recruited from a hospital setting by using posters and by a social media campaign
Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
In this study, a new, non-invasive method for diagnosis of pulmonary embolism (PE) will be tested.
A teljes eredeti leírásKevesebb
In pre-clinical studies, the investigators have identified 151 putative biomarkers for pulmonary embolism in the exhaled breath, and several of these were also found in a first in-human clinical study what the investigators performed in 2019-2020 (DOI 10.1088/1752-7163/ad0aaa). These biomarkers need consolidation in a clinical setting using an updated collection device and proteomic analysis platform before development of a prototype and further test of this new diagnostic method.
A vizsgálat 3 csoportja
- PE confirmed
Patients admitted with confirmed pulmonary embolism.
Kezelés: New method for diagnosis of pulmonary embolism (PE) in order to validate/consolidate 151 putative identified biomarkers for PE in the exhaled breath.
- PE suspected
Patients admitted with suspected, but not confirmed pulmonary embolism.
Kezelés: New method for diagnosis of pulmonary embolism (PE) in order to validate/consolidate 151 putative identified biomarkers for PE in the exhaled breath.
- Controls
Healthy controls - same gender and age (within af range of 10 years) as PE patients.
Kezelés: New method for diagnosis of pulmonary embolism (PE) in order to validate/consolidate 151 putative identified biomarkers for PE in the exhaled breath.
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- A regiszteradat frissítve
- 2025. január 13.